IL152241A0 - Methods for ansamitocin production - Google Patents

Methods for ansamitocin production

Info

Publication number
IL152241A0
IL152241A0 IL15224101A IL15224101A IL152241A0 IL 152241 A0 IL152241 A0 IL 152241A0 IL 15224101 A IL15224101 A IL 15224101A IL 15224101 A IL15224101 A IL 15224101A IL 152241 A0 IL152241 A0 IL 152241A0
Authority
IL
Israel
Prior art keywords
methods
ansamitocin
production
ansamitocin production
Prior art date
Application number
IL15224101A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL152241A0 publication Critical patent/IL152241A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL15224101A 2000-04-12 2001-04-11 Methods for ansamitocin production IL152241A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19636100P 2000-04-12 2000-04-12
PCT/GB2001/001661 WO2001077360A2 (en) 2000-04-12 2001-04-11 Methods for ansamitocin production

Publications (1)

Publication Number Publication Date
IL152241A0 true IL152241A0 (en) 2003-05-29

Family

ID=22725075

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15224101A IL152241A0 (en) 2000-04-12 2001-04-11 Methods for ansamitocin production

Country Status (21)

Country Link
US (2) US6573074B2 (zh)
EP (1) EP1272653B1 (zh)
JP (1) JP4832697B2 (zh)
KR (1) KR20030036159A (zh)
CN (1) CN1432068A (zh)
AR (1) AR028002A1 (zh)
AT (1) ATE331804T1 (zh)
AU (2) AU9333501A (zh)
BR (1) BR0109975A (zh)
CA (1) CA2406188A1 (zh)
CZ (1) CZ20023356A3 (zh)
DE (1) DE60121150T2 (zh)
ES (1) ES2266243T3 (zh)
HU (1) HUP0300473A3 (zh)
IL (1) IL152241A0 (zh)
MX (1) MXPA02010109A (zh)
NO (1) NO20024893D0 (zh)
NZ (1) NZ521868A (zh)
PL (1) PL365577A1 (zh)
WO (1) WO2001077360A2 (zh)
ZA (1) ZA200208159B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
JP2006510349A (ja) * 2002-08-08 2006-03-30 スミスクライン・ビーチャム・コーポレイション アンサミトシンの単離および精製方法
WO2005020883A2 (en) * 2003-05-08 2005-03-10 Immunogen, Inc. Methods for the production of ansamitocins
US7432088B2 (en) * 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
US7276497B2 (en) * 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
US20070135629A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
EP1806365A1 (en) 2006-01-05 2007-07-11 Boehringer Ingelheim International GmbH Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
CN100420754C (zh) * 2006-10-26 2008-09-24 浙江海正药业股份有限公司 一种制备蒽莎姆菌素的方法
PT3415531T (pt) 2011-05-27 2023-09-12 Glaxo Group Ltd Proteínas de ligação a bcma (cd269/tnfrsf17
CN102505023A (zh) * 2011-11-18 2012-06-20 华东理工大学 一种dahp合酶的异源可溶性表达方法及其重组载体和基因工程菌
CN108276427A (zh) * 2018-01-14 2018-07-13 常州大学 一种安丝菌素p-3的提取与分离纯化方法
CN110117626A (zh) * 2018-02-06 2019-08-13 上海键合医药科技有限公司 一种制备安丝菌素p3的发酵工艺
US11420981B2 (en) 2019-04-18 2022-08-23 Indena S.P.A. Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
CN113444106A (zh) * 2020-03-25 2021-09-28 重庆乾泰生物医药有限公司 一种高纯度安丝菌素的制备方法
BR112023024804A2 (pt) 2021-05-28 2024-02-15 Glaxosmithkline Ip Dev Ltd Terapias de combinação para tratar câncer
CN117597450A (zh) * 2021-06-18 2024-02-23 杭州中美华东制药有限公司 安丝菌素p-3的提纯方法
WO2023057893A1 (en) 2021-10-05 2023-04-13 Glaxosmithkline Intellectual Property Development Limited Combination therapies for treating cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1314019A (en) * 1969-07-19 1973-04-18 Rolland Sa A Antibiotic substance and process for the extraction of such an antibiotic substance from a strain of pseudomonas
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
JPS6010718B2 (ja) 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル，メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
US4162940A (en) 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS6016236B2 (ja) 1977-11-18 1985-04-24 武田薬品工業株式会社 抗生物質ｃ―１５００３ ｐ―３の製造法
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) * 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
US4423211A (en) * 1981-12-21 1983-12-27 Merck & Co., Inc. Process for the whole broth extraction of avermectin
JPH0347090A (ja) * 1988-12-27 1991-02-28 Takeda Chem Ind Ltd 二重特異性を有するハイブリッドモノクローナル抗体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
CA2069439A1 (en) 1989-12-15 1991-06-16 Susumu Iwasa Monoclonal antibodies, their production and use
FR2656874B1 (fr) * 1990-01-11 1992-04-03 Commissariat Energie Atomique Procede de production et d'extraction d'anti-oxydants a partir d'une culture de micro-organismes et photobioreacteur pour la mise en óoeuvre de ce procede.
DE4037441A1 (de) * 1990-11-24 1992-05-27 Basf Ag Verfahren zur erhoehung des riboflavin-gahaltes in spruehgetrockneten fermenteraustraegen bei riboflavin-fermentationen
JPH08214870A (ja) * 1995-02-17 1996-08-27 Kanegafuchi Chem Ind Co Ltd ファフィア・ロドチーマ酵母の細胞壁処理方法
CN1056845C (zh) * 1995-03-03 2000-09-27 弗·哈夫曼-拉罗切有限公司 核黄素的纯化

Also Published As

Publication number Publication date
AU9333501A (en) 2001-10-23
EP1272653A2 (en) 2003-01-08
NO20024893L (no) 2002-10-10
US6573074B2 (en) 2003-06-03
ATE331804T1 (de) 2006-07-15
EP1272653B1 (en) 2006-06-28
JP4832697B2 (ja) 2011-12-07
HUP0300473A3 (en) 2004-07-28
JP2003530114A (ja) 2003-10-14
AU2001293335B2 (en) 2005-02-24
PL365577A1 (en) 2005-01-10
DE60121150T2 (de) 2007-05-16
BR0109975A (pt) 2004-03-23
ES2266243T3 (es) 2007-03-01
WO2001077360A3 (en) 2002-09-12
US20020015984A1 (en) 2002-02-07
AR028002A1 (es) 2003-04-23
DE60121150D1 (de) 2006-08-10
MXPA02010109A (es) 2003-02-12
NO20024893D0 (no) 2002-10-10
CZ20023356A3 (cs) 2003-04-16
US20030157669A1 (en) 2003-08-21
WO2001077360A2 (en) 2001-10-18
CA2406188A1 (en) 2001-10-18
CN1432068A (zh) 2003-07-23
ZA200208159B (en) 2003-10-17
KR20030036159A (ko) 2003-05-09
HUP0300473A2 (hu) 2003-06-28
NZ521868A (en) 2004-11-26

Similar Documents

Publication Publication Date Title
IL152241A0 (en) Methods for ansamitocin production
AU2001295611A1 (en) Multipressure method for producing ammonia
HUP0104566A3 (en) Process for producing n-carboxi-anhidrides
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
HK1049327A1 (zh) 製備氨基二苯基胺的方法
AU2002210535A1 (en) Method for producing melamine
AU1053502A (en) Method for producing melamine
PL361146A1 (en) Method for producing isocyanato-organosilanes
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
AU2001250505A1 (en) Method for reducing sand production
AU2001231726A1 (en) Method for producing monoglycosidated flavonoids
EP1343354A4 (en) METHOD FOR MANUFACTURING A HIGH SPEAKER
AU3734301A (en) Method for producing 2-chloro-benzimidazole derivatives
AU4273501A (en) Process for producing camptothecin
AU2001242735A1 (en) Process for producing camptothecin
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2001268019A1 (en) Method for hydrogen production
AU7265900A (en) Method for producing otoplastics
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU8444201A (en) Process for producing fluoroalkanol
AU2001284442A1 (en) Process for producing fluoroalkanol
AU2001287723A1 (en) Method for producing delta 1-pyrrolines
HUP0301141A3 (en) Method for the production of trioxime derivatives